---
schema_version: "secwatch.filing_event.v1"
accession: "0001438133-25-000112"
form_type: "8-K"
ticker: "TNDM"
cik: "0001438133"
company_name: "TANDEM DIABETES CARE INC"
filed_at: "2025-05-23T23:59:59+00:00"
generated_at: "2026-05-20T13:45:05.631992+00:00"
event_type: "litigation"
sentiment: "neutral"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Tandem settles patent disputes with Roche, agrees to pay $36M over five years

## Summary
- Settlement resolves pending patent actions in France and Germany regarding t:slim X2 pump and two EP patents.
- Total consideration $36M; initial $8M payment due, remainder in four equal annual installments.
- Parties exchange non-exclusive, non-royalty-bearing cross-licenses to insulin delivery system patents for 10 years.
- Tandem and Roche mutually release claims and covenant not to sue related to the disputed patents.

## SEC filing metadata
- accession: 0001438133-25-000112
- form_type: 8-K
- ticker: TNDM
- cik: 0001438133
- company_name: TANDEM DIABETES CARE INC
- filed_at: 2025-05-23T23:59:59+00:00
- event_type: litigation
- sentiment: neutral
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 1.01, 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1438133/000143813325000112/0001438133-25-000112-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1438133/000143813325000112/tndm-20250521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001438133-25-000112
- JSON: https://secwatch.observer/filing/0001438133-25-000112.json
- Plain text: https://secwatch.observer/filing/0001438133-25-000112.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.